"But microdosing has not been well studied in clinical trials, and most of the data is anecdotal." She said that when someone asks her about microdosing a GLP-1, she advises that, since it's off-label (meaning not approved by the FDA), carefully monitoring their blood sugar, weight, and symptoms is essential
Research shows that while these drugs can be highly effective for weight loss, they dont distinguish between fat and musclean important distinction, since losing muscle can raise your risk of injuries, osteoporosis, and reduced mobility
however it increases when used in conjunction with insulin or insulin secretagogues (Garber 2011)
Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid GLP-1 receptor agonists
Renuvion compliments liposuction by tightening that loose skin internally, delivering results that are both sculpted and smooth